摘要
目的探讨利巴韦林联合穿琥宁治疗上呼吸道感染的临床效果。方法回顾性分析本院收治的100例上呼吸道感染患者的临床资料,根据治疗方法不同分为治疗组和对照组各50例,其中对照组患者单用利巴韦林治疗,治疗组患者在对照组的基础上加用穿琥宁治疗,比较两组临床疗效和症状消失时间。结果治疗组总有效率为94.0%,对照组总有效率为84.0%,两组差异有统计学意义(P<0.05);治疗组患者体温恢复正常时间、咳嗽消除时间、咽痛缓解时间均显著短于对照组(P<0.05)。结论利巴韦林联合穿琥宁治疗上呼吸道感染疗效显著,值得应用。
Objective To investigate the clinical effect of ribavirin with potassium dehydroandrograpolide succinate in treatment of upper respiratory tract infection.Methods The clinical data of 100 cases of patients with upper respiratory tract infection in our hospital was taken for retrospective analysis.According to treatment methods,they were divided into the treatment group and the control group,and 50 cases in each group.The control group was only given ribavirin,and the control group was given potassium dehydroandrograpolide succinate on the basis of the control group.The clinical efficacy and symptoms extinction time of two groups were compared.Results After treatment,the total effective rate in the treatment group was 94.0%,and the total efficiency was 84.0% in the control group,the difference between two groups was significant（P＆lt;0.05）;the body temperature recover time,cough extinction time,sore throat relief time of treatment group was significantly less than the control group（P＆lt;0.05）.Conclusion The clinical effect of ribavirin with potassium dehydroandrograpolide succinate in treatment of upper respiratory tract infection is significant,is worthy of application.
出处
《中国当代医药》
2013年第23期97-98,共2页
China Modern Medicine
关键词
利巴韦林
穿琥宁
上呼吸道感染
Ribavirin
Potassium dehydroandrograpolide succinate
Upper respiratory tract infection
